"Designing Growth Strategies is in our DNA"

Patient Warming Devices Market Size, Share & Industry Analysis, By Product Type (External Patient Warming Devices, Blood & IV Fluid Warming Devices, Internal/Core Warming Devices, and Dedicated Consumables & Accessories), By Application (Surgical & Perioperative Warming, Emergency, Trauma & Resuscitation, Critical Care Warming, Obstetric & Maternal Warming, and Others), By End-user (Hospitals & ASCs, Emergency Medical & Prehospital Services, Specialty Clinics & Non-ASC Procedure Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: November 19, 2026 | Format: PDF | Report ID: FBI119766

 

Patient Warming Devices Market Size and Future Outlook

Play Audio Listen to Audio Version

The global patient warming devices market size was valued at USD 2.09 billion in 2025. The market is projected to grow from USD 2.22 billion in 2026 to USD 3.74 billion by 2034, exhibiting a CAGR of 6.7% during the forecast period.

Patient warming devices are medical systems used to prevent or treat hypothermia and maintain normal body core temperature during and after surgical procedures. The global market growth is driven by rising volume of surgical procedures, strict hospital safety protocols to prevent perioperative hypothermia, and an increasing aging population.

Solventum, ICU Medical, Inc., TSC Life, Medtronic, and Belmont Medical Technologies held the highest market share in 2025 due to their well-established brand trust and product reputation worldwide.

Integrated, Precision, and Closed-Loop Temperature Management to Emerge as a Kaey Trend

Currently, patient warming systems are gaining traction and becoming more advanced and integrated. Moreover, the newer systems combine several functions such as temperature monitoring, patient positioning, automatic temperature control, pressure management, and data recording. This becomes vital in complex surgeries and critical-care settings due to the necessity of maintaining a stable body temperature.

Furthermore, integrated systems simplify operating-room workflows by reducing the number of separate devices required around the patient. Also, connected temperature-management systems have been improving documentation and supporting quality-monitoring programs in hospitals. This is benefiting key players with expertise across temperature sensors, electronics, thermal-control technology, software, and patient-support systems.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Surgical and Anesthesia Volumes and Stronger Normothermia Protocols to Drive Market Growth

Over the past few years, there has been an increase in surgical and anesthesia volumes worldwide. Anesthesia reduces the body’s ability to control temperature during surgery, while the risk of unintended hypothermia increases due to long procedures. Therefore, hospitals & ambulatory surgical centers are placing greater emphasis on keeping patients warm before, during, and after procedures. Patient warming has also become a standard part of perioperative safety protocols and is influencing hospitals to use patient warming devices actively to maintain normal body temperature throughout surgery. This is anticipated to drive patient warming devices market growth in the forthcoming years.

  • For instance, as of September 2026, the Joint Commission states that around 40.0 million anesthetics are administered annually in the U.S. This is directly increasing the need for patient warming systems.

Market Drivers - Impact & CAGR Contribution (2026–2034)

Rank Market Drivers Overall Impact Rank CAGR Contribution (2026-34) Impact: 2026-2028 Impact: 2029-2031 Impact: 2032-2034
1 Rising surgical and anesthesia volumes and stronger normothermia protocols High 2.70% High High High
2 Expansion of blood/fluid warming in trauma, transfusion and resuscitation High 2.20% High High High
3 Growth in hospital, ASC, ICU and emergency-care infrastructure Medium-High 1.85% Medium High High
4 Recurring consumable pull-through from installed warming systems Medium 1.55% Medium Medium Medium
5 Portable, precision and integrated warming technology adoption Medium-Low 1.35% Medium Medium Low
6 Others (aging populations, obstetric demand, replacement cycles, emerging-market modernization, distribution expansion) Low 1.03% Low Low Low
Total Positive Growth Contribution 10.68%  

Source: Fortune Business Insights

Download Free sample For In-Depth Market Restraints & Risk Analysis

MARKET RESTRAINTS

Procurement Price Pressure and Recurring Consumable Cost to Restrict Market Growth

Despite the growing demand for patient warming devices, high price sensitivity among small hospitals and healthcare facilities is expected to hinder the adoption of these devices. The warming systems themselves are generally less expensive; the imaging or robotic systems, the ongoing cost of disposable blankets, and others add to a high total cost of ownership.

In emerging countries, the budget constraints also encourage hospitals to keep existing warming equipment in use for longer, which may slow replacement demand. Such a scenario is anticipated to hinder the market growth over the forecast period.

Market Restraints - Impact & Negative CAGR Contribution (2026–2034)

Rank Market Restraints Overall Impact Rank Negative CAGR Contribution (2026-34)
(2026-2034)
Impact: 2026-2028 Impact: 2029-2031 Impact: 2032-2034
1 Procurement price pressure and recurring consumable cost High -1.45% High High High
2 Safety, recall, quality-system and regulatory-compliance burden Medium-High -1.15% High Medium Medium
3 Uneven access and low active-warming penetration in resource-constrained settings Medium-Low -0.93% Medium Medium Low
4 Others (replacement-cycle extension, training constraints, passive-warming substitution, logistics and tender delays) Low -0.45% Low Low Low
Total Negative Growth Impact -3.98%  

Source: Fortune Business Insights

Download Free sample For In-Depth Market Restraints & Risk Analysis

MARKET OPPORTUNITIES

Portable Blood/Fluid Warming Beyond the Operating Room to Create Growth Opportunities

Portable blood and fluid warming systems are gaining traction outside traditional operating rooms. These devices can be used in ambulances, military settings, field hospitals, air ambulances, and remote emergency-care locations where rapid warming of blood and IV fluids may be needed.

In several countries, many healthcare settings are still less developed than hospital operating rooms in terms of warming-device adoption. In such a scenario, if emergency medical services begin carrying blood products and whole blood, the demand for compact and easy-to-use warming systems is expected to gain traction. This is anticipated to drive the market’s expansion during the forecast period.

MARKET CHALLENGES

Safety, Thermal Performance, and Post-Market Risk to Challenge the Market Expansion

In developed countries, the patient warming devices must provide effective warming while maintaining a high level of safety. If a system delivers too much heat, too little heat, or inconsistent performance, it can increase risks such as burns, overheating, inadequate warming, or treatment delays. Additionally, performance is affected by fluid flow rate, inlet temperature, blanket placement, and other factors.

Moreover, manufacturers also face ongoing post-market responsibilities such as problems with single-use components, software, and cybersecurity requirements. Also, any recall or field action can disrupt hospital workflows, which require replacement of inventory and create additional training needs.

  • For instance, in 2025 the FDA classified a recall involving 3M Ranger High Flow Sets as Class I. The action involved concerns related to flow rates and inlet/outlet temperature information. Such a scenario is anticipated to challenge the market’s expansion.

Segmentation Analysis

By Product Type

Widespread Usage and Large Installed Base of Forced-Air Warming Systems to Support External Patient Warming Devices Segment’s Growth

Based on product type, the market is segmented into external patient warming devices, blood & IV fluid warming devices, internal/core warming devices, and dedicated consumables & accessories.

The external patient warming devices segment accounted for the largest global patient warming devices market share in 2025 due to widespread use during surgery and a large installed base of forced-air warming systems. Moreover, their well-established use in operating rooms is also expected to support the segment’s growth.

The blood & IV fluid warming devices segment is projected to grow at a CAGR of 7.8% during the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Application

Increasing Surgical Volumes to Support Surgical & Perioperative Warming Segment’s Growth

By application, the market is classified into surgical & perioperative warming, emergency, trauma & resuscitation, critical care warming, obstetric & maternal warming, and others.

The surgical & perioperative warming segment accounted for the largest market share in 2025. The segment’s growth is attributed to an increasing number of surgeries and perioperative procedures. These increasing volumes are driving the need to maintain normal body temperature before, during, and after surgery, especially because anesthesia reduces the body’s natural ability to regulate temperature. Moreover, the segment is set to acquire a 65.5% share by 2026.

  • In November 2024, the American Joint Replacement Registry (AJRR) surpassed 4.0 million hip and knee arthroplasty procedures.

The emergency, trauma & resuscitation segment is expected to grow at a CAGR of 7.9% during the forecast period.

By End-user

Higher Potential of Hospitals and Shift of Surgical Procedures to Outpatient Settings to Fuel the Hospitals & ASCs Segment’s Growth

On the basis of end-user, the market is segmented into hospitals & ASCs, emergency medical & prehospital services, specialty clinics & non-ASC procedure centers, and others.

In 2025, the hospitals & ASCs segment dominated the market due to the greater potential of these settings to perform numerous surgeries and anesthesia procedures. Moreover, the increasing shift of these procedures to outpatient settings is further expected to drive the segment’s growth. Furthermore, the segment is set to hold an 84.0% market share by 2026.

The specialty clinics & non-ASC procedure centers segment is projected to grow at a CAGR of 7.9% during the forecast period.

Patient Warming Devices Market Regional Outlook

Based on region, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

North America Patient Warming Devices Market Size, 2025 (USD Billion)

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest share in 2024, valued at USD 0.84 billion. It maintained its leading position in 2025, with USD 0.89 billion, primarily due to the advanced hospital infrastructure, strong network of ASCs, and higher product penetration in the region.

  • For instance, as of March 2025, the Centers for Medicare & Medicaid Services (CMS) stated that there were over 6,500 Medicare-certified ASCs in the U.S.

U.S. Patient Warming Devices Market

In 2026, the U.S. is anticipated to reach USD 0.86 billion, accounting for approximately 38.7% of global sales.

Europe

Europe is projected to record a CAGR of 5.7% during the forecast period, the second-highest globally. The market is expected to reach USD 0.58 billion by 2026. The region’s growth is primarily due to the presence of key players and well-established healthcare infrastructure favoring adoption of patient warming devices.

U.K. Patient Warming Devices Market

The U.K. market size is projected to reach USD 0.09 billion by 2026, representing approximately 4.3% of global sales.

Germany Patient Warming Devices Market

Germany's market value is expected to reach USD 0.12 billion by 2026, accounting for approximately 5.2% of global revenues.

Asia Pacific

In 2026, the market in Asia Pacific is projected to reach approximately USD 0.52 billion, making it the third-largest market. The region’s growth is due to a large patient pool in India and China, which is driving surgical volume and ultimately supporting the adoption of patient warming devices.

Japan Patient Warming Devices Market

Japan is projected to reach approximately USD 0.11 billion in revenue in 2026, representing nearly 4.8% of global sales.

China Patient Warming Devices Market

In 2026, China is anticipated to reach USD 0.15 billion, accounting for approximately 6.8% of global sales.

India Patient Warming Devices Market

In 2026, India is anticipated to reach USD 0.07 billion, accounting for approximately 2.9% of global sales.

Latin America and Middle East & Africa

Latin America and the Middle East & Africa regions are anticipated to witness moderate growth during the forecast period. The Latin America market size is estimated to reach approximately USD 0.10 billion by 2026. Latin America growth is supported by recovery of elective surgery, public-system capacity initiatives, and adoption of modern perioperative and transfusion practices. Moreover, the market growth of the Middle East & Africa is mainly attributed to increasing healthcare infrastructure investment and high-acuity care, which is expected to drive the demand for premium warming technologies.

GCC Patient Warming Devices Market

In 2026, the GCC market size is estimated to reach approximately USD 0.02 billion, representing around 1.0% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Broad Product Portfolio and Strong Foothold of Major Companies to Increase Market Share Globally

In 2025, Solventum, ICU Medical, Inc., TSC Life, Medtronic, and Belmont Medical Technologies held the largest global market share. The dominance of these companies is attributed to their broad product portfolio and significant focus on new launches.

Moreover, other prominent players are focusing on key strategic initiatives such as facility expansions, geographic expansion, and increasing R&D investments. This is expected to enhance their market share in the forthcoming years.

LIST OF KEY PATIENT WARMING DEVICES COMPANIES PROFILED

  • Solventum (U.S.)
  • ICU Medical, Inc. (U.S.)
  • TSC Life (Netherlands)
  • Medtronic (Ireland)
  • Belmont Medical Technologies (U.S.)
  • ZOLL Medical Corporation (U.S.)
  • Medline Industries, LP (U.S.)
  • GENTHERM (U.S.)
  • Care Essentials (Australia)
  • Mölnlycke Health Care AB (Sweden)

KEY INDUSTRY DEVELOPMENTS

  • July 2026: GENTHERM received FDA 510(k) clearance for ThermAffyx, an integrated warming, securement, and pressure-reduction platform designed for robotic surgery workflows.
  • July 2026: GENTHERM acquired Innovative Medical Equipment, provider of the ThermaZone thermal therapy device, expanding the Medical portfolio and channel access.
  • June 2025: 3T Medical Systems acquired the Altrix Precision Temperature Management System from Stryker, adding a precision thermal-management platform to its portfolio.
  • October 2024: TSC Life announced that direct U.S. management of Mistral-Air would begin 1 January 2025, replacing the prior Stryker distribution arrangement and increasing direct commercial control.
  • April 2024: Solventum became an independent healthcare company following its separation from 3M.
  • January 2024: TSC Life was launched through the combination of the Surgical Company’s patient temperature management business with other specialist assets, retaining Mistral-Air and Fluido as core warming franchises.

REPORT COVERAGE

The report offers detailed analysis of the global patient warming devices market across its key segments. It covers the major drivers, restraints, opportunities, challenges, and trends contributing to market growth. The study further examines technological advancements, key industry developments, competitive analysis, market share analysis, and detailed profiles of prominent companies operating in the market.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 6.7% from 2026-2034
Unit Value (USD Billion)
Segmentation By Product Type, Application, End-user, and Region
By Product Type
  • External Patient Warming Devices
  • Blood & IV Fluid Warming Devices
  • Internal/Core Warming Devices
  • Dedicated Consumables & Accessories
By Application
  • Surgical & Perioperative Warming
  • Emergency, Trauma & Resuscitation
  • Critical Care Warming
  • Obstetric & Maternal Warming
  • Others
By End-user
  • Hospitals & ASCs
  • Emergency Medical & Prehospital Services
  • Specialty Clinics & Non-ASC Procedure Centers
  • Others
By Region
  • North America (By Product Type, Application, End-user, and Country)
    • U.S. (Application)
    • Canada (Application)
  • Europe (By Product Type, Application, End-user, and Country/Sub-region)
    • Germany (Application)
    • U.K. (Application)
    • France (Application)
    • Spain (Application)
    • Italy (Application)
    • Scandinavia (Application)
    • Rest of Europe (Application)
  • Asia Pacific (By Product Type, Application, End-user, and Country/Sub-region)
    • China (Application)
    • Japan (Application)
    • India (Application)
    • Australia (Application)
    • Southeast Asia (Application)
    • Rest of Asia Pacific (Application)
  • Latin America (By Product Type, Application, End-user, and Country/Sub-region)
    • Brazil (Application)
    • Mexico (Application)
    • Rest of Latin America (Application)
  • Middle East & Africa (By Product Type, Application, End-user, and Country/Sub-region)
    • GCC (Application)
    • South Africa (Application)
    • Rest of the Middle East & Africa (Application)

Research Methodology

1. Bottom Up Approaches

Approach 1: Revenues and Market Share of Major Players

  • Collection of patient-warming-attributable revenues from annual reports, SEC filings, investor presentations, earnings releases, and company/product websites of Solventum, ICU Medical, TSC Life, Medtronic, Belmont Medical Technologies, Gentherm, ZOLL Medical, and other key manufacturers.
  • Estimation of company market share using product revenues, regional presence, installed base, hospital/ASC penetration, system placements, replacement cycles, recurring consumable sales, and manufacturer ASPs.
  • Triangulation of company revenues with regional and country-level demand indicators to estimate the global market.

Approach 2: Installed Base, Unit Demand & ASP Analysis

  • Estimation of installed base and annual placements/replacements of external patient warming systems, blood & IV fluid warmers, and internal/core warming devices.
  • Assessment of manufacturer ASPs by product category, country, and procurement environment.
  • Separate estimation of capital equipment revenues and recurring revenues from blankets, gowns, fluid warming sets, heat exchangers, catheters, and other dedicated consumables.
  • Aggregation of country-level device and consumable revenues to arrive at regional and global market values.

Approach 3: Procedure & Utilization Model

  • Analysis of surgical and anesthesia procedures, emergency/trauma cases, ICU utilization, blood transfusion/resuscitation activity, obstetric procedures, and other clinical episodes requiring patient warming.
  • Estimation of patient-warming penetration, utilization per procedure, consumables per procedure, and adoption of active warming technologies across countries.
  • Procedure volumes × warming utilization × units/consumables per procedure × manufacturer ASP were used to estimate country-level demand and validate the global market.

2. Top Down Approaches

Approach 4: Healthcare Spending & Clinical Demand Analysis

  • Analysis of healthcare expenditure, medical-device spending, hospital and ASC infrastructure, operating-room capacity, ICU capacity, emergency-care infrastructure, and healthcare technology adoption across major countries.
  • Patient-warming demand was calibrated against surgical volumes, anesthesia exposure, transfusion activity, healthcare access, procurement intensity, replacement demand, and local pricing.
  • Regional estimates were cross-checked against manufacturer revenues and bottom-up installed-base/procedure models before deriving the final global market.

3. List of Key Sources

  • Annual reports, SEC filings, investor presentations, earnings releases, sustainability reports, and official product catalogs/websites
  • FDA, European Commission/EU MDR, PMDA, NMPA, CDSCO, TGA, and national health authorities
  • WHO, OECD, Eurostat, World Bank, and national healthcare databases
  • Medical Device Manufacturers Association, MedTech Europe, CAMDI, Medical Technology Association of Australia, and relevant anesthesia/perioperative/critical-care societies
  • Peer-reviewed clinical literature, perioperative hypothermia guidelines, surgical statistics, ICU data, blood-transfusion data, regulatory approvals, product launches, recalls, procurement activity, tender awards, and reimbursement developments

4. Primary Interviews

Supply Side Interviews: 60%

  • Key Respondents:
    • Patient warming device manufacturers, distributors, procurement specialists, product managers, sales executives, regional managers, and medical-device suppliers.
    • Discussions focused on market size, product pricing, installed base, replacement cycles, competitive position, distribution structure, consumable utilization, regional demand, and technology adoption.

Demand Side Interviews: 40%

  • Key Respondents:
    • Anesthesiologists, surgeons, perioperative nurses, ICU professionals, emergency/trauma clinicians, hospital procurement teams, and healthcare administrators.
    • Discussions focused on patient-warming practices, technology preferences, utilization frequency, procurement criteria, clinical adoption, product replacement, consumable usage, and differences in adoption across countries and care settings.


Frequently Asked Questions

Fortune Business Insights says that the global market value stood at USD 2.09 billion in 2025 and is projected to reach USD 3.74 billion by 2034.

The market is expected to exhibit a CAGR of 6.7% during the forecast period.

By product type, the external patient warming devices segment led the market.

The key factors driving the market are the rising surgical and anesthesia volumes and stronger normothermia protocols.

Solventum, ICU Medical, Inc., TSC Life, Medtronic, and Belmont Medical Technologies are among the top players in the market.

North America dominated the market in 2025.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 250
Download Free Sample

    man icon
    Mail icon
    Mail icon
Jump to Content

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann